This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Parsyan, A. Articles by Allain, J.-P. Search for Related Content PubMed PubMed Citation Articles by Parsyan, A. Articles by Allain, J.-P.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, April 2006, p. 1367-1375, Vol. 44, No. 4
0095-1137/06/$08.00+0     doi:10.1128/JCM.44.4.1367-1375.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Reactivity of Genotype-Specific Recombinant Proteins of Human Erythrovirus B19 with Plasmas from Areas Where Genotype 1 or 3 Is Endemic

Division of Transfusion Medicine, Department of Haematology, University of Cambridge, Cambridge, United Kingdom,¹ National Blood Service, Cambridge Blood Centre, Cambridge, United Kingdom,² Biotrin Ltd., Dublin, Ireland,³ Transfusion Medicine Unit, Department of Medicine, Komfo Anokye Teaching Hospital, Kumasi, Ghana⁴

Received 13 December 2005/ Returned for modification 6 February 2006/ Accepted 12 February 2006

Human erythrovirus (parvovirus) B19 (B19) is a common human pathogen. The recent discovery of three genotypes, 1 to 3, raised issues related to the ability of genotype-specific antigens to cross-react with antibodies elicited by other genotypes. This study assessed antibody capture and immunoglobulin G (IgG) cross-reactivity between genotype 1 and genotype 3 recombinant antigens and analyzed the potential gain of adding VP1 protein to VP2 capsid antigen. Plasma samples from genotype 1- or genotype 3-infected populations were blindly tested with blindly prepared reagents. The IgG reactivity was assessed with baculovirus-expressed VP2 or VP1 and VP2 recombinant genotype 1 or genotype 3 proteins in a standardized enzyme immunoassay (EIA). A high degree of agreement (>95%) between EIA results was observed, with Spearman correlation coefficient and kappa reliability coefficient results of 0.95 for samples from the United Kingdom and 0.77 for samples from Ghanaian children, respectively. Most discrepant results were related to equivocal reactivity. The addition of VP1 to VP2 capsids did not significantly impact antibody detection. These data suggest that the currently available genotype-1-based IgG EIA is suitable to detect antibody to B19 genotype 3 in Ghanaian children. However, samples from the Ghanaian adult population exhibited atypical results in the assay, possibly due to the high levels of nonspecific IgG antibodies found in adults living in this region. Within these limitations, the study demonstrates that genotype 1 and genotype 3 antigens are equally effective in detecting either antibody species.

This article has been cited by other articles:

• Fryer, J. F., Delwart, E., Bernardin, F., Tuke, P. W., Lukashov, V. V., Baylis, S. A. (2007). Analysis of two human parvovirus PARV4 genotypes identified in human plasma for fractionation. J. Gen. Virol. 88: 2162-2167 [Abstract] [Full Text]  
• Ekman, A., Hokynar, K., Kakkola, L., Kantola, K., Hedman, L., Bonden, H., Gessner, M., Aberham, C., Norja, P., Miettinen, S., Hedman, K., Soderlund-Venermo, M. (2007). Biological and Immunological Relations among Human Parvovirus B19 Genotypes 1 to 3. J. Virol. 81: 6927-6935 [Abstract] [Full Text]  
• Parsyan, A., Szmaragd, C., Allain, J.-P., Candotti, D. (2007). Identification and genetic diversity of two human parvovirus B19 genotype 3 subtypes. J. Gen. Virol. 88: 428-431 [Abstract] [Full Text]  
• Norja, P., Hokynar, K., Aaltonen, L.-M., Chen, R., Ranki, A., Partio, E. K., Kiviluoto, O., Davidkin, I., Leivo, T., Eis-Hubinger, A. M., Schneider, B., Fischer, H.-P., Tolba, R., Vapalahti, O., Vaheri, A., Soderlund-Venermo, M., Hedman, K. (2006). Bioportfolio: Lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc. Natl. Acad. Sci. USA 103: 7450-7453 [Abstract] [Full Text]